Pathogen and autoantigen homologous regions within the cystic fibrosis transmembrane conductance regulator (CFTR) protein suggest an autoimmune treatable component of cystic fibrosis

FEMS Immunology and Medical Microbiology

Volumn 62, Issue 2, 2011, Pages 197-214

  Carter, Chris J ^a  

^a Polygenic Pathways   (United Kingdom)

Author keywords

Autoantigen; Autoimmunity; Cystic fibrosis; Mimicry; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

AUTOANTIGEN; BACTERIAL PROTEIN; CALGRANULIN; MYELOPEROXIDASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; CARDIOMYOPATHY; COMORBIDITY; CYSTIC FIBROSIS; DIABETES MELLITUS; IMMUNITY; LIFESPAN; NUCLEOTIDE SEQUENCE; PANCREAS; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS INFECTION; STENOTROPHOMONAS MALTOPHILIA; T LYMPHOCYTE; UNINDEXED SEQUENCE; VAS DEFERENS;

AUTOANTIGENS; COMPUTATIONAL BIOLOGY; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; PSEUDOMONAS AERUGINOSA; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA;

EID: 79958804737     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00803.x     Document Type: Article

References (89)

1. Agarwal A, Sarkar S, Nazabal C, Balasundaram G & Rao KV (1996) B cell responses to a peptide epitope. I. The cellular basis for restricted recognition. J Immunol 157: 2779-2788.
2. Ajonuma LC, Fok KL, Ho LS et al. (2010) CFTR is required for cellular entry and internalization of Chlamydia trachomatis. Cell Biol Int 34: 593-600.
3. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W & Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402.
4. Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D & Hubert D (1999) HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am J Resp Crit Care 159: 1464-1468.
5. Bhal GK, Maguire SA & Bowler IM (2001) Use of cyclosporin A as a steroid sparing agent in cystic fibrosis. Arch Dis Child 84: 89.
6. Carter CJ (2010a) Alzheimer's disease: a pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner. Int J Alzheimers Dis DOI: DOI: 10.4061/2010/140539.
7. Carter CJ (2010b) Herpes simplex: host viral protein interactions. Available at (accessed October 2010).
8. Chanson M, Scerri I & Suter S (1999) Defective regulation of gap junctional coupling in cystic fibrosis pancreatic duct cells. J Clin Invest 103: 1677-1684.
9. Chatr-aryamontri A, Ceol A, Peluso D et al. (2009) VirusMINT: a viral protein interaction database. Nucleic Acids Res 37: D669-D673.
10. Coffey M, Hassan J, Feighery C, Fitzgerald M & Bresnihan B (1989) Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections. Clin Exp Immunol 77: 52-57.
11. Coutinho HD (2007) Burkholderia cepacia complex: virulence characteristics, importance and relationship with cystic fibrosis. Indian J Med Sci 61: 422-429.
12. Czerska K, Sobczynska-Tomaszewska A, Sands D, Nowakowska A, Bak D, Wertheim K, Poznanski J, Zielenski J, Norek A & Bal J (2010) Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients. J Appl Genetics 51: 323-330.
13. D'Cruz OJ, Dunn TS, Pichan P, Hass GG Jr & Sachdev GP (1996) Antigenic cross-reactivity of human tracheal mucin with human sperm and trophoblasts correlates with the expression of mucin 8 gene messenger ribonucleic acid in reproductive tract tissues. Fertil Steril 66: 316-326.
14. Deriy LV, Gomez EA, Zhang G, Beacham DW, Hopson JA, Gallan AJ, Shevchenko PD, Bindokas VP & Nelson DJ (2009) Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages. J Biol Chem 284: 35926-35938.
15. Doring G & Worlitzsch D (2000) Inflammation in cystic fibrosis and its management. Paediatr Respir Rev 1: 101-106.
16. Doring G, Albus A & Hoiby N (1988) Immunologic aspects of cystic fibrosis. Chest 94: 109S-115S.
17. Elde NC & Malik HS (2009) The evolutionary conundrum of pathogen mimicry. Nat Rev Microbiol 7: 787-797.
18. Elsbach P (1998) The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense. J Leukocyte Biol 64: 14-18.
19. Endoh Y, Chung YM, Clark IA, Geczy CL & Hsu K (2009) IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA. J Immunol 182: 2258-2268.
20. Forde AM, Feighery C & Jackson J (1998) Characterisation of anti-neutrophil cytoplasmic antibody target antigens using electrophoresis and western blotting techniques. Brit J Biomed Sci 55: 247-252.
21. Fraser CM & Venter JC (1982) Autoantibodies to beta 2-adrenergic receptors and allergic respiratory disease. Surv Immunol Res 1: 365-370.
22. Fraternale A, Paoletti MF, Casabianca A, Nencioni L, Garaci E, Palamara AT & Magnani M (2009) GSH and analogs in antiviral therapy. Mol Aspects Med 30: 99-110.
23. Gatti E & Pierre P (2003) Understanding the cell biology of antigen presentation: the dendritic cell contribution. Curr Opin Cell Biol 15: 468-473.
24. Godfrey RW (1997) Human airway epithelial tight junctions. Microsc Res Techniq 38: 488-499.
25. Goto S, Bono H, Ogata H, Fujibuchi W, Nishioka T, Sato K & Kanehisa M (1997) Organizing and computing metabolic pathway data in terms of binary relations. Pac Symp Biocomput 1: 175-186.
26. Hampton TH & Stanton BA (2010) A novel approach to analyze gene expression data demonstrates that the DeltaF508 mutation in CFTR downregulates the antigen presentation pathway. Am J Physiol-Lung C 298: L473-L482.
27. Herout V, Benesova D, Vavrova V, Vanicek H, Hrobonova V, Tycova V, Marek J & Kokstejn Z (1990) Cardiomyopathy and changes of skeletal muscles in cystic fibrosis. Acta U Carol Med 36: 201-203.
28. Hillian AD, Londono D, Dunn JM, Goddard KA, Pace RG, Knowles MR & Drumm ML (2008) Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun 9: 501-508.
29. Hurbain I, Sermet-Gaudelus I, Vallee B, Feuillet MN, Lenoir G, Bernaudin JF, Edelman A & Fajac A (2003) Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the delta F508 mutation. Pediatr Res 54: 627-634.
30. Jarzabek K, Zbucka M, Pepinski W, Szamatowicz J, Domitrz J, Janica J, Wolczynski S & Szamatowicz M (2004) Cystic fibrosis as a cause of infertility. Reprod Biol 4: 119-129.
31. Jensen P, Johansen HK, Carmi P, Hoiby N & Cohen IR (2001) Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis. J Autoimmun 17: 165-172.
32. Jin R, Hodges CA, Drumm ML & Palmert MR (2006) The cystic fibrosis transmembrane conductance regulator (Cftr) modulates the timing of puberty in mice. J Med Genet 43: e29.
33. Johannesson M, Askling J, Montgomery SM, Ekbom A & Bahmanyar S (2009) Cancer risk among patients with cystic fibrosis and their first-degree relatives. Int J Cancer 125: 2953-2956.
34. John G, Yildirim AO, Rubin BK, Gruenert DC & Henke MO (2010) TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. Am J Resp Cell Mol 42: 424-431.
35. Kaiser GI, Laszlo A & Gyurkovits K (1977) Cystic fibrosis: a HLA associated hereditary disease? Acta Paediatr Hung 18: 27-29.
36. Kerbiriou M, Teng L, Benz N, Trouve P & Ferec C (2009) The calpain, caspase 12, caspase 3 cascade leading to apoptosis is altered in F508del-CFTR expressing cells. PLoS One 4: e8436.
37. Knight RA, Kollnberger S, Madden B, Yacoub M & Hodson ME (1997) Defective antigen presentation by lavage cells from terminal patients with cystic fibrosis. Clin Exp Immunol 107: 542-547.
38. Lachenal F, Nkana K, Nove-Josserand R, Fabien N & Durieu I (2009) Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis. Eur Respir J 34: 1079-1085.
39. Laki J, Laki I, Nemeth K et al. (2006) The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis. Int Immunol 18: 1585-1590.
40. Larsen JE, Lund O & Nielsen M (2006) Improved method for predicting linear B-cell epitopes. Immunome Res 2: 1-10.
41. Levy H, Murphy A, Zou F et al. (2009) IL1B polymorphisms modulate cystic fibrosis lung disease. Pediatr Pulm 44: 580-593.
42. l'Hoste S, Chargui A, Belfodil R, Corcelle E, Duranton C, Rubera I, Poujeol C, Mograbi B, Tauc M & Poujeol P (2010) CFTR mediates apoptotic volume decrease and cell death by controlling glutathione efflux and ROS production in cultured mice proximal tubules. Am J Physiol-Renal 298: F435-F453.
43. Libby DM, Gibofsky A, Fotino M, Waters SJ & Smith JP (1983) Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2. Am Rev Respir Dis 127: 618-622.
44. LiPuma JJ (2010) The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 23: 299-323.
45. Machen TE (2006a) Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol-Cell Ph 291: C218-C230.
46. Machen TE (2006b) Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol-Cell Ph 291: C218-C230.
47. McDonald TV, Nghiem PT, Gardner P & Martens CL (1992) Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current. J Biol Chem 267: 3242-3248.
48. McMillan SA, Hill AJ, Graham CA, Nevin NC & Fay AC (1989) T cell receptor beta chain polymorphisms are associated with cystic fibrosis. J Med Genet 26: 431-433.
49. Merlo CA & Boyle MP (2003) Modifier genes in cystic fibrosis lung disease. J Lab Clin Med 141: 237-241.
50. Moss AJ (1982) The cardiovascular system in cystic fibrosis. Pediatrics 70: 728-741.
51. Nathan BM, Laguna T & Moran A (2010) Recent trends in cystic fibrosis-related diabetes. Curr Opin Endocrinol Diabetes Obes 17: 335-341.
52. Nembrini C, Marsland BJ & Kopf M (2009) IL-17-producing T cells in lung immunity and inflammation. J Allergy Clin Immun 123: 986-994.
53. Neumann AU, Phillips S, Levine I, Ijaz S, Dahari H, Eren R, Dagan S & Naoumov NV (2010) Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells. Hepatology 52: 875-885.
54. Ng A, Bursteinas B, Gao Q, Mollison E & Zvelebil M (2006) pSTIING: a 'systems' approach towards integrating signalling pathways, interaction and transcriptional regulatory networks in inflammation and cancer. Nucleic Acids Res 34: D527-D534.
55. Nielsen M, Lundegaard C, Lund O & Kesmir C (2005) The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57: 33-41.
56. Paez PL, Becerra MC & Albesa I (2010) Effect of the association of reduced glutathione and ciprofloxacin on the antimicrobial activity in Staphylococcus aureus. FEMS Microbiol Lett 303: 101-105.
57. Painter RG, Marrero L, Lombard GA, Valentine VG, Nauseef WM & Wang G (2010) CFTR-mediated halide transport in phagosomes of human neutrophils. J Leukocyte Biol 87: 933-942.
58. Paul S (2008) Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. Bioessays 30: 1172-1184.
59. Pedersen SK, Sloane AJ, Prasad SS, Sebastian LT, Lindner RA, Hsu M, Robinson M, Bye PT, Weinberger RP & Harry JL (2005a) An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis. Mol Cell Proteomics 4: 1052-1060.
60. Pedersen SK, Sloane AJ, Prasad SS, Sebastian LT, Lindner RA, Hsu M, Robinson M, Bye PT, Weinberger RP & Harry JL (2005b) An immunoproteomic approach for identification of clinical biomarkers for monitoring disease: application to cystic fibrosis. Mol Cell Proteomics 4: 1052-1060.
61. Pfaller CK & Conzelmann KK (2008) Measles virus V protein is a decoy substrate for IkappaB kinase alpha and prevents Toll-like receptor 7/9-mediated interferon induction. J Virol 82: 12365-12373.
62. Pier GB, Grout M, Zaidi TS & Goldberg JB (1996) How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis. Am J Resp Crit Care 154: S175-S182.
63. Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, Ratcliff R, Evans MJ & Colledge WH (1998) Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393: 79-82.
64. Rottner M, Freyssinet JM & Martinez MC (2009) Mechanisms of the noxious inflammatory cycle in cystic fibrosis. Respir Res 10: 23-28.
65. Roum JH, Buhl R, McElvaney NG, Borok Z & Crystal RG (1993) Systemic deficiency of glutathione in cystic fibrosis. J Appl Physiol 75: 2419-2424.
66. Roum JH, Borok Z, McElvaney NG, Grimes GJ, Bokser AD, Buhl R & Crystal RG (1999) Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. J Appl Physiol 87: 438-443.
67. Scheithauer S, Haase G, Hausler M, Lemmen S, Ritter K & Kleines M (2010) Association between respiratory and herpes viruses on pulmonary exacerbations in cystic fibrosis patients. J Cyst Fibros 9: 234-236.
68. Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT & Pier GB (2001) Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract. J Immunol 166: 7410-7418.
69. Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerceker AA, Golan DE & Pier GB (2002) CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. P Natl Acad Sci USA 99: 6907-6912.
70. Schubert ML (2010) Gastric secretion. Curr Opin Gastroen 26: 598-603.
71. Sediva A, Bartunkova J, Kolarova I, Hrusak O, Vavrova V, Macek M Jr, Lockwood CM & Dunn AC (1998) Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis. J Autoimmun 11: 185-190.
72. Sikkens EC, Cahen DL, Kuipers EJ & Bruno MJ (2010) Pancreatic enzyme replacement therapy in chronic pancreatitis. Best Pract Res Cl Ga 24: 337-347.
73. Stalvey MS, Brusko TM, Mueller C, Wasserfall CH, Schatz DA, Atkinson MA & Flotte TR (2008) CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes. Cytokine 44: 154-159.
74. Stanke F, Becker T, Kumar V et al. (2010) Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. J Med Genet 48: 24-31.
75. Stechova K, Kolouskova S, Sumnik Z et al. (2005) Anti-GAD65 reactive peripheral blood mononuclear cells in the pathogenesis of cystic fibrosis related diabetes mellitus. Autoimmunity 38: 319-323.
76. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P & Fagerhol MK (1990) Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 336: 763-765.
77. Sweezey NB, Smith D, Corey M, Ellis L, Carpenter S, Tullis DE, Durie P & O'Brodovich HM (2007) Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis. Pediatr Pulm 42: 519-524.
78. Taylor TJ, Brockman MA, McNamee EE & Knipe DM (2002) Herpes simplex virus. Front Biosci 7: d752-d764.
79. Tesse R, Cardinale F, Santostasi T, Polizzi A, Mappa L, Manca A, De Robertis F, Silecchia O & Armenio L (2008) Association of interleukin-10 gene haplotypes with Pseudomonas aeruginosa airway colonization in cystic fibrosis. J Cyst Fibros 7: 329-332.
80. Toma J, Whitcomb JM, Petropoulos CJ & Huang W (2010) Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors. AIDS 24: 2181-2186.
81. Toussirot E & Roudier J (2008) Epstein-Barr virus in autoimmune diseases. Best Pract Res Cl Rh 22: 883-896.
82. Vij N, Mazur S & Zeitlin PL (2009) CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS One 4: e4664.
83. Vincenzi F, Bizzarri B, Ghiselli A, de' AN, Fornaroli F & de' Angelis GL (2010) Cystic fibrosis and Crohn's disease: successful treatment and long term remission with infliximab. World J Gastroentero 16: 1924-1927.
84. Wagner S, Janzen RW, Mohs C, Pohlmann S, Klingel R & Grutzmacher PW (2008) Long-term treatment of refractory myasthenia gravis with immunoadsorption [Langzeitbehandlung der therapierefraktaren Myasthenia gravis mittels Immunadsorption. DEP - 20081104]. Deut Med Wochenschr 133: 2377-2382.
85. Wang X, Venable J, LaPointe P et al. (2006) Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127: 803-815.
86. Waters V, Yau Y, Prasad S, Lu A, Atenafu E, Crandall I, Tom S, Tullis E & Ratjen F (2010) Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am J Resp Crit Care 183: 635-640.
87. Westall FC (2006) Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 44: 2099-2104.
88. Wine JJ, Brayden DJ, Hagiwara G, Krouse ME, Law TC, Muller UJ, Solc CK, Ward CL, Widdicombe JH & Xia Y (1991) Cystic fibrosis, the CFTR, and rectifying Cl- channels. Adv Exp Med Biol 290: 253-269.
89. Zhang Y & Duan K (2009) Glutathione exhibits antibacterial activity and increases tetracycline efficacy against Pseudomonas aeruginosa. Sci China Ser C 52: 501-505.